Regulus Therapeutics Inc.

NASDAQ: RGLS · Real-Time Price · USD
7.97
0.03 (0.38%)
At close: Jun 03, 2025, 3:59 PM
7.99
0.25%
After-hours: Jun 03, 2025, 07:26 PM EDT
0.38%
Bid 7.8
Market Cap 551.8M
Revenue (ttm) n/a
Net Income (ttm) -47.52M
EPS (ttm) -0.68
PE Ratio (ttm) -11.72
Forward PE -7.5
Analyst Hold
Ask 8
Volume 742,981
Avg. Volume (20D) 1,994,230
Open 7.98
Previous Close 7.94
Day's Range 7.94 - 7.99
52-Week Range 0.83 - 8.20
Beta 0.50

About RGLS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGLS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RGLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+136.8%
Regulus Therapeutics shares are trading higher aft... Unlock content with Pro Subscription
2 months ago
+16.28%
Regulus Therapeutics shares are trading higher after the company announced topline results from the phase 1b MAD study of Farabursen for autosomal dominant polycystic kidney disease.